在社区瘤实践中实施静脉血栓栓塞预防计划:一个队列研究
Steven Ades1, Yonatan Resnick2, Jacob Barker3
1University of Vermont Cancer Center, 89 Beaumont Ave, Burlington, VT 05405, USA.
Lancet regional health. Americas
|September 16, 2024
概括
在社区瘤实践中实施维蒙特模式的静脉血栓栓塞 (VTE) 风险评估,提高了患者教育和风险评估率. 开始抗凝剂预防的数量略有增加,这表明需要解决处方障碍.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 实施科学 实施科学
背景情况:
- 国家指导方针主张在癌症门诊患者中进行静脉血栓栓塞 (VTE) 风险评估.
- 对于高风险患者,建议进行药物预防,但在社区瘤学中采用率较低.
- 佛蒙特模型 (VM) 是一个在学术环境中经过验证的指导方针实施策略.
研究的目的:
- 将弗蒙特模型 (VM) 适用于VTE风险评估和预防,适应社区瘤实践环境.
- 在多个社区瘤学站点实施适应的VM.
- 评估适应VM的临床和实施结果.
主要方法:
- 一个多学科团队调整了VM,包括电子病历 (EMR) 优化和临床医生教育.
- 适应的VM已经实施,并纳入了利益相关者的反.
- 临床和实施结果在实施后的六个月被前性评估.
主要成果:
- 在为期6个月的实施期内,包括302名癌症门诊患者.
- 风险教育达到了100%的患者,98%的患者接受了风险评估.
- 在高危患者中 (18%),27%的人开始预防;障碍包括EMR问题,时间,药物相互作用和财务问题.
结论:
- 多学科的VTE预防模型成功地提高了社区瘤学中的VTE教育和风险评估.
- 抗凝血剂预防率略有增加,强调需要解决处方障碍.
- 需要进一步的战略来优化社区癌症护理机构的VTE预防.
相关概念视频
Nursing Implementation
4.9K
Implementation is the execution of the nursing care plan developed during the planning phase.
The five steps to implementing effective nursing care include reassessing the patient, reviewing and revising the existing nursing care plan, organizing the resources and care delivery, anticipating and preventing complications, and implementing nursing interventions.
The five steps to implementing effective nursing care include reassessing the patient, reviewing and revising the existing nursing care plan, organizing the resources and care delivery, anticipating and preventing complications, and implementing nursing interventions.
4.9K
Healthcare Associated Infections II: Preventive Measures
2.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.5K
Overview of Systemic Veins
444
Systemic veins are crucial blood vessels that return deoxygenated blood from various body tissues back to the heart. There are three systemic veins that return deoxygenated blood to the heart, they are as follows.
The coronary sinus, the heart's principal vein, resides in the coronary sulcus on the heart's posterior aspect. This broad venous channel receives nearly all venous blood from the myocardium, the heart muscle. It is fed by three primary veins: the great cardiac vein, the...
The coronary sinus, the heart's principal vein, resides in the coronary sulcus on the heart's posterior aspect. This broad venous channel receives nearly all venous blood from the myocardium, the heart muscle. It is fed by three primary veins: the great cardiac vein, the...
444
Levels of Health Promotion and Illness Prevention
12.5K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
12.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
160
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
160


